• Home
  • Clinical Topics
    • Cardiovascular Disease
    • Diabetes
    • Hematology
    • Infectious disease
    • Mental health / PTSD
    • Neurology
    • Oncology
    • Orthopedics
    • Pain management
    • Pulmonology
    • Rheumatology
    • Women’s health
  • Non-Clinical Topics
    • Legislation
    • Personnel
    • Policy
    • Research
    • Pharmacy Update
    • Technology
  • Special Issues
    • 2026 Compendium of Federal Medicine
    • Advances in Treatment for Serious Clinical Depression in the Military and Va
    • Evolving Therapies at VA Improve Colorectal Cancer Survival
    • Advances in Use of Therapy Combinations for Recurrent Relapsed Multiple Myeloma at VA
    • 2026 USM Directory
    • Advances in Wound Care
    • Operationalization of Bispecific Therapy Supplement
  • Departments
    • Department of Veterans Affairs (VA)
    • Military Health System
    • Public Health Service
  • Opinion
  • Subscription
    • Print Subscription
    • e-Newsletter Subscription
  • Contact Us
Diabetes Staging System Improves Care for Type 2 Diabetes Patients In VA Primary Care Clinics 

Diabetes Staging System Improves Care for Type 2 Diabetes Patients In VA Primary Care Clinics 

by LaTina Emerson | Jul 8, 2026

Guideline-concordant care for veteran Type 2 diabetes (T2D) patients improved with use of the Diabetes Staging System to guide treatment, predict survival and create a shared language for care in VA primary care clinics.

Survey Found Improved Peritoneal Dialysis Program Infrastructure and Clinical Practices at VHA

by U.S. Medicine | Jun 16, 2026

Peritoneal dialysis (PD) use among the U.S. veterans is lower than that in the nonveteran kidney failure population. The VA has made access to high quality home dialysis a strategic priority.

Results Similar Between IV and Oral Iron Replacement Therapy With Mitigation

by U.S. Medicine | Jun 13, 2026

Noting that the long-term outcomes associated with intravenous (IV) vs. oral iron replacement therapy in patients with chronic kidney disease have been unclear, a recent study sought to remedy that.

CGM Data Predicts Kidney Decline, Cuts ESRD Risk in VA Diabetes Studies

by Annette Boyle | Jun 11, 2026

VA researchers also find TBI doubles dementia risk in type 2 diabetes; stress tied to diabetes onset; and metformin linked to slower biological aging

How Has the Epidemiology of CKD Changed Among Veterans, Others?

by U.S. Medicine | Mar 15, 2026

The prevalence of kidney disease is higher among older, female, non-Hispanic Black adults and those with diabetes or hypertension, according to survey data.

Veterans With CKD Survived Longer With Telenephrology Care

by U.S. Medicine | Mar 15, 2026

Has providing access to nephrology specialists improved care for veterans with chronic kidney disease (CKD) in remote areas?

End-stage Renal Disease, Patients Treated for Rare Blood Disorder at Lower Risk of Mortality

by LaTina Emerson | Dec 10, 2025

Patients with end-stage renal disease (ESRD) with thrombotic thrombocytopenic purpura (TTP) who are treated by therapeutic plasma exchange (TPE) are at lower risk of mortality than ESRD patients without this diagnosis. That indicated that TPE is warranted when there is clinical suspicion of TTP, according to a recent study.

Urine Biomarkers of Kidney Tubular Function Linked to Risk of Death, Heart Failure Readmission

by LaTina Emerson | Nov 19, 2025

In patients admitted to the hospital with acute heart failure, five urine biomarkers of kidney tubular function were found to be associated with risk of death and heart failure readmission, according to a recent study.

Selecting Diabetes Medications: Which GLP-1RAs Are Safest, Most Effective?

by Brenda Mooney | Nov 14, 2025

The medication class glucagon-like peptide-1 receptor agonists (GLP-1RAs) might be at the center of discussion in medicine these days, but a new study pointed out that the comparative effectiveness and safety of individual formulations have not been well understood.

Albuminuria More Than eGFR Linked to Kidney Cancer

by U.S. Medicine | Oct 24, 2025

While studies have previously examined the association of chronic kidney disease (CKD) with cancer risk, results have been conflicting.

Even Mild CKD Can Affect Alzheimer’s Blood Biomarkers

by U.S. Medicine | Oct 22, 2025

How chronic kidney disease (CKD) affects Alzheimer’s disease (AD) plasma biomarkers is poorly understood.

Lower Risk of Kidney Failure in HF Patients on High-Dose RAS Inhibitors

by U.S. Medicine | Jun 13, 2025

Renin-angiotensin system (RAS) inhibitors are known to reduce the risk of kidney failure in chronic kidney disease patients but worsen kidney function in heart failure patients, especially in those with chronic kidney disease.

CVD, CKD Combine to Increase Surgical Mortality

by U.S. Medicine | Mar 17, 2025

What are the interactive effects of cardiovascular disease (CVD) and chronic kidney disease (CKD) on long-term mortality following major operations?

How Different Heart Failure Types Are Affected by CKD

by U.S. Medicine | Mar 17, 2025

Chronic kidney disease (CKD) is defined by the KDIGO (Kidney Disease: Improving Global Outcomes) guideline as abnormal kidney structure or function, present for more than 3 months, with implications for health.

Decreasing Renal Function Affects PAD Treatment

by U.S. Medicine | Mar 17, 2025

What is the impact of the severity of chronic kidney disease (CKD) on mortality and major adverse limb events (MALE) after endovascular revascularization of the superficial femoral artery (SFA)?

More Benefit From Intensive BP Control in Veterans With CKD Than Original SPRINT Participants

by Brenda Mooney | Feb 10, 2025

The Systolic Blood Pressure Intervention Trial (SPRINT) found benefits of intensive vs. standard blood pressure (BP) control. But do those findings generalize to adults with chronic kidney disease (CKD)?

Discontinuing SGLT2is, GLP-1 RAs Linked to Negative Outcomes in CKD Patients

by LaTina Emerson | Oct 15, 2024

Discontinuation of sodium-glucose co-transporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RA) is common but is associated with harmful outcomes in adults with chronic kidney disease (CKD), according to a recent study.

Homelessness Substantially Increases Risk of Death in Veterans With CKD

by Brenda Mooney | Oct 14, 2024

U.S. veterans with a history of homelessness had a much greater risk of end-stage kidney disease (ESKD) and death, according to a new study, underscoring the role of housing as a social determinant of health.

Early Dialysis Leads to Modest Gains in Life Expectancy, Less Home Time

Early Dialysis Leads to Modest Gains in Life Expectancy, Less Home Time

by LaTina Emerson | Oct 14, 2024

Older adults with reduced kidney function who start dialysis within 30 days and aren’t referred for transplant have modest gains in life expectancy and less time at home, according to a recent study.

Breaking Barriers in Kidney Care: Cynthia Delgado’s Pioneering Efforts Lead to More Equitable Transplantation Practices at the VA

by Annette Boyle | Oct 13, 2024

For more than two decades, the calculation of estimated glomerular filtration rate (eGFR) — a critical measure of kidney function — included race as a variable.

Anti-TNF Agents Associated With Kidney Function Decline in IBD Patients

by Mary Anne Dunkin | Sep 15, 2024

The introduction of biologic therapies, such as antitumor necrosis factor (TNF) agents, has revolutionized the management of inflammatory bowel disease (IBD)—a group of diseases characterized by chronic inflammation of the gastrointestinal tract.

Recurrent Hyperkalemia Found to Be Higher in Black, Hispanic Veterans

by LaTina Emerson | Jul 11, 2024

In U.S. veterans with incident hyperkalemia, the risk of recurrent hyperkalemia within one year is higher in Black and Hispanic patients, according to a recent study.

Kidney Disease Defined by KDIGO Guidelines Riskier for Veterans With HF

by U.S. Medicine | Jul 10, 2024

Is chronic kidney disease (CKD) diagnosed based on a single estimated glomerular filtration rate measurement significantly different from that diagnosed using the Kidney Disease: Improving Global Outcomes (KDIGO) guideline?

Diabetic CKD Progression Faster in Veterans Than General Population

by LaTina Emerson | Jun 10, 2024

Veterans with diabetic kidney disease have a faster rate of stage progression compared to patients in the general population, and more than half of veteran diabetic kidney disease patients progressed to an advanced stage or died within 5 years, according to a recent study.

Thiazide Diuretics Associated With Reduced Risk of Kidney Stones

by LaTina Emerson | Apr 10, 2024

Using thiazide diuretics is associated with statistically significant lower odds of developing kidney stones, which supports the use of the products for kidney stone prevention, according to a recent study.

Cause of Kidney Injury After Procedures Not Always Contrast Media

by U.S. Medicine | Mar 12, 2024

The administration of iodinated contrast media is not responsible for all changes in creatinine levels in patients undergoing the procedures.

Black Veterans Get CKD Younger, Have Lower Death Rates

by U.S. Medicine | Mar 12, 2024

The younger age of chronic kidney disease (CKD) in Black patients can help explain some of the differences and disparities compared to white patients with CKD, according to a new study.

Much More Dual Testing for CKD Needed Within VHA

by U.S. Medicine | Mar 12, 2024

A new study that included VA researchers made the case for much more dual testing for chronic kidney disease (CKD) in high-risk patients to improve disease management and patient outcomes.

Unstable Housing Increases Veterans’ Mortality Risk With Kidney Dialysis

by Brenda Mooney | Dec 6, 2023

Unstable housing appears to contribute to socioeconomic disparities in mortality among U.S. veterans receiving dialysis, with older adults being especially vulnerable, according to a new study

BTK Inhibitors Provide Option for CLL Patients With Severe Renal Dysfunction

by U.S. Medicine | Dec 9, 2023

BTK inhibitors have proven to be a powerful tool in CLL treatment and have replaced chemoimmunotherapy as the preferred first-line treatment.

Subscribe to the print edition of U.S. Medicine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and Indian Health Service.

Subscribe Now

Sign up to receive the U.S. Medicine e-Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

 Sign Up

  • For Advertisers
  • e-Newsletter
  • Subscribe to U.S. Medicine Print Publication
  • About Us
  • Privacy Policy
  • Do Not Sell or Share My Personal Information
  • Limit the Use of My Sensitive Personal Information
  • Terms of Use